Verano Holdings VRNO
OTC VRNO
$6.21 +0.16 (+2.64%)
As of: Aug 21, 2026 · 3:59 PM EDT

Verano Holdings (VRNO) Change in Account Payables (2021 - 2026)

Verano Holdings (VRNO) posted quarterly Change in Account Payables of -$5.7 million for Q1 2026, down 175.52% year-over-year from $7.6 million in Q1 2025, and down 329.87% quarter-over-quarter from -$1.3 million in Q4 2025.

Verano Holdings (VRNO) Change in Account Payables (2021 - 2026) Analysis & Trends

Verano Holdings (VRNO) has reported Change in Account Payables for 6 consecutive years, with -$5.7 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Change in Account Payables fell 175.52% year-over-year to -$5.7 million; the TTM figure through Mar 2026 stood at -$7.9 million (down 206.61% YoY), while the FY2025 annual figure was $5.4 million, up 228.5% from the prior year.
  • Change in Account Payables slipped to -$5.7 million in Q1 2026 per VRNO's latest filing, from -$1.3 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $19.9 million in Q1 2022 and bottomed at -$13.7 million in Q4 2022.
  • Historically, Change in Account Payables has averaged -$1.2 million across 5 years, with a median of -$3.0 million in 2024.
  • On a YoY basis, Change in Account Payables climbed as much as 2522.59% in 2024 and fell as far as 495.85% in 2024.
  • Verano Holdings' Change in Account Payables stood at -$13.7 million in 2022, then jumped by 96.32% to -$506000.0 in 2023, then tumbled by 495.85% to -$3.0 million in 2024, then soared by 55.92% to -$1.3 million in 2025, then slumped by 329.87% to -$5.7 million in 2026.
  • Business Quant data shows VRNO's Change in Account Payables at -$5.7 million in Q1 2026, -$1.3 million in Q4 2025, and $5.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -53.00 Mn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -143.74 Mn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn -
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn -21.20 Mn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn -
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Verano Holdings 449.04 Mn 363.85 Mn 99.70 Mn -2.38 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.38 Mn
Jun 30, 2026 -2.38 Mn
Mar 31, 2026 -5.71 Mn
Mar 31, 2026 -5.71 Mn
Dec 31, 2025 -1.33 Mn
Dec 31, 2025 -1.33 Mn
Sep 30, 2025 5.35 Mn
Sep 30, 2025 5.35 Mn
Jun 30, 2025 -6.21 Mn
Jun 30, 2025 -6.21 Mn
Mar 31, 2025 7.57 Mn
Mar 31, 2025 7.57 Mn
Dec 31, 2024 -3.02 Mn
Dec 31, 2024 -3.02 Mn
Sep 30, 2024 8.71 Mn
Sep 30, 2024 8.71 Mn
Jun 30, 2024 -5.84 Mn
Jun 30, 2024 -5.84 Mn
Mar 31, 2024 -4.03 Mn
Mar 31, 2024 -4.03 Mn